ATE488603T1 - Suszeptibilitätsgen für die alzheimersche krankheit - Google Patents

Suszeptibilitätsgen für die alzheimersche krankheit

Info

Publication number
ATE488603T1
ATE488603T1 AT04734298T AT04734298T ATE488603T1 AT E488603 T1 ATE488603 T1 AT E488603T1 AT 04734298 T AT04734298 T AT 04734298T AT 04734298 T AT04734298 T AT 04734298T AT E488603 T1 ATE488603 T1 AT E488603T1
Authority
AT
Austria
Prior art keywords
alzheimer
disease
susceptibility gene
polymorphism
susceptibility
Prior art date
Application number
AT04734298T
Other languages
English (en)
Inventor
Zsuzsanna Nagy
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of ATE488603T1 publication Critical patent/ATE488603T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04734298T 2003-05-22 2004-05-21 Suszeptibilitätsgen für die alzheimersche krankheit ATE488603T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0311835.3A GB0311835D0 (en) 2003-05-22 2003-05-22 Susceptibility gene for alzheimer's disease
PCT/GB2004/002222 WO2004104226A1 (en) 2003-05-22 2004-05-21 Susceptibility gene for alzheimer's disease

Publications (1)

Publication Number Publication Date
ATE488603T1 true ATE488603T1 (de) 2010-12-15

Family

ID=9958611

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04734298T ATE488603T1 (de) 2003-05-22 2004-05-21 Suszeptibilitätsgen für die alzheimersche krankheit

Country Status (7)

Country Link
US (2) US7842455B2 (de)
EP (1) EP1627077B1 (de)
AT (1) ATE488603T1 (de)
DE (1) DE602004030107D1 (de)
ES (1) ES2354525T3 (de)
GB (1) GB0311835D0 (de)
WO (1) WO2004104226A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
GB0311835D0 (en) 2003-05-22 2003-06-25 Isis Innovation Susceptibility gene for alzheimer's disease
WO2008131367A2 (en) * 2007-04-20 2008-10-30 Translational Genomics Research Institute Methods of diagnosing alzheimer's disease and markers identified by set association
CN103092336B (zh) * 2011-10-28 2017-11-24 Mplus株式会社 振动装置及包括该振动装置的触觉反馈装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0106051D0 (en) * 2001-03-12 2001-05-02 Isis Innovation Diagnostic screens for alzheimer's disease
GB0311835D0 (en) 2003-05-22 2003-06-25 Isis Innovation Susceptibility gene for alzheimer's disease

Also Published As

Publication number Publication date
DE602004030107D1 (de) 2010-12-30
ES2354525T3 (es) 2011-03-15
US8137916B2 (en) 2012-03-20
US7842455B2 (en) 2010-11-30
EP1627077B1 (de) 2010-11-17
GB0311835D0 (en) 2003-06-25
US20070072184A1 (en) 2007-03-29
EP1627077A1 (de) 2006-02-22
WO2004104226A1 (en) 2004-12-02
US20110045486A1 (en) 2011-02-24

Similar Documents

Publication Publication Date Title
EP1246114A3 (de) Verfahren zur Genomanalyse
ATE522626T1 (de) Verfahren und nukleotid-sequenzen, die bevorzugt die expression eines mutierten huntingtin-genes unterdrücken
ATE470723T1 (de) Genexpressionsmarker für die prognose von brustkrebs
ATE386942T1 (de) Verfahren zur voraussage, zur diagnose und zur vergleichenden diagnose von alzheimer
EP4249602A3 (de) Verfahren zur erstellung von bibliotheken von matrizen-polynukleotiden
WO2004037988A3 (en) Methods for synthesizing complementary dna
ITMI20021737A1 (it) Processo di purificazione di nanotubi di carbonio.
WO2003044176A3 (en) Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
WO2007119179A3 (en) Use of the ornithine transcarbamylase (otc), as a marker for diagnosing brain damages
HUP0402030A2 (hu) Új nukleinsav-szekvenciák és alkalmazásuk növényekben patogén-rezisztencia kialakítására szolgáló eljárásokban
MX2009001937A (es) Biomarcadores para el progreso de la enfermedad de alzheimer.
WO2003046203A3 (en) Genetic markers associated with desirable and undesirable traits in horses, methods of identifying and using such markers
MX2009008964A (es) Metodo y producto para genotipado "in vitro" con aplicacion en medicina anti-envejecimiento.
WO2007050705A3 (en) Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof
MXPA05008793A (es) Metodos para la prediccion de posibilidad de suicidio durante el tratamiento.
DK0749498T3 (da) Genetiske markører, der i forening anvendes til diagnose af Alzheimer's sygdom, metode og diagnosekit
DK1730315T3 (da) Polymorphismer i NOD2/Card15 gen
ATE488603T1 (de) Suszeptibilitätsgen für die alzheimersche krankheit
DK1692517T3 (da) Anvendelse af ADAM 12 til diagnosticering af præeklampsi
EP1743036A4 (de) Mit dem alter bei erstauftreten von alzheimer im zusammenhang stehende apoe-genmarker
DK1656458T3 (da) Human autisme-susceptibilitetsgen og anvendelser deraf
DK1664102T3 (da) Isoleret photoprotein mtclytin, samt dets anvendelse
WO2003064600A3 (en) The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
MXPA05005120A (es) Secuencias de adn de la region genomica tcd de photorhabdus luminescens.
WO2005052180A3 (en) Ntrk1 genetic markers associated with progression of alzheimer’s disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties